Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225478 · ClinicalTrials.gov registry record · Phase 3
Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 180
- Enrollment target
NCT07225478 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 180 participants.
The verdict
NCT07225478, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 180 participants
- Enrollment target
Study Summary
The goal of this clinical study is to evaluate how well a new in-office whitening system works to whiten teeth compared to some other commercially available in-office whitening systems.
Interventions
- DRUG Fluoride Toothpaste
- DEVICE Soft Manual Toothbrush
- DRUG Beaming White
- COMBINATION_PRODUCT Philips Zoom Professional Whitening Treatment
- COMBINATION_PRODUCT Opalescence Boost PF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-10-31 |
| Est. Completion | 2025-12-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07225478
The ClinicalTrials.gov registry entry for NCT07225478 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Fluoride Toothpaste is the first listed.
NCT07225478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07225478 about?
NCT07225478 is a clinical study titled "Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System". The goal of this clinical study is to evaluate how well a new in-office whitening system works to whiten teeth compared to some other commercially available in-office whitening systems.
What is the current status of trial NCT07225478?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2025-10-31. Estimated completion is 2025-12-21.
What interventions are being tested in trial NCT07225478?
The interventions under investigation include: Fluoride Toothpaste (DRUG), Soft Manual Toothbrush (DEVICE), Beaming White (DRUG), Philips Zoom Professional Whitening Treatment (COMBINATION_PRODUCT), Opalescence Boost PF (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07225478?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.